Using individual level-data, the paper uncovers patient and drug characteristics that determine the probability of using the original patented products despite the presence of generic substitutes in the Czech Republic in the period 2009-2013. Our results reveal different behavioral patterns for...

Although personalized medicine is becoming the new paradigm to manage some diseases, the economics of personalized medicine have only focused on assessing the efficiency of specific treatments, lacking a theoretical framework analyzing the interactions between pharmaceutical firms and healthcare...